Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
about
Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune responseAntigen-independent adhesion and cell spreading by inducible costimulator engagement inhibits T cell migration in a PI-3K-dependent manner.ICOS promotes IL-17 synthesis in colonic intraepithelial lymphocytes in IL-10-/- mice.Upregulation of ICOS on CD43+ CD4+ murine small intestinal intraepithelial lymphocytes during acute reovirus infection.Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cellsMaternal microchimerism in pediatric inflammatory bowel disease.Possible role of REG Ialpha protein in ulcerative colitis and colitic cancerInhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.T-cell activation in the intestinal mucosa.Costimulatory pathways: physiology and potential therapeutic manipulation in systemic lupus erythematosus.Massive but selective cytokine dysregulation in the colon of IL-10-/- mice revealed by multiplex analysis.Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection.The genomic architecture of mastitis resistance in dairy sheep.Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases.Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele.Association of CTLA-4 gene microsatellite polymorphism with ulcerative colitis in Chinese patients.
P2860
Q28267161-382941E6-E2AE-4557-A7CD-9AE5AFABABDAQ30486421-03FFE878-8FCD-402F-B889-A3B382250A8FQ33615233-E116A3AB-36AD-45CA-84FD-2BBAC08D6981Q33951453-9EF55D3C-FF10-43AA-B5AC-92DA003F2236Q35096555-96185C56-CA20-4369-A8ED-63AEFCA0B51BQ35194858-E5F7598C-406E-439F-B6B2-704F22D44AACQ35597803-CD3AD667-F03B-46F2-A802-BEA1CB6F23BCQ36014379-E1603361-A293-400E-AA84-6498E010D243Q36732698-B7447D72-25B6-4633-996A-6032D3508942Q37127290-D4BCE2BF-E0ED-4DC0-9748-45F108CCEA6DQ37372628-B18976ED-DC0D-4A15-B2C2-FB26AEE83812Q37446021-95DD7151-185F-4C4E-A5F3-C514BA5A9C1BQ38621713-21F6B773-1A07-4C82-9945-6A2C35277731Q39152159-3A1CC40A-5D68-41F4-A48D-4683D882C58BQ40976985-5CC87D6E-3D45-474F-95F7-8C14A5A54472Q42046686-3E8047F2-3EDE-45DD-B6FF-6AAE0D9391E4Q54604075-42121296-E528-4D92-87D8-128A27B18726
P2860
Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Hyperexpression of inducible c ...... in inflammatory bowel disease.
@en
Hyperexpression of inducible c ...... in inflammatory bowel disease.
@nl
type
label
Hyperexpression of inducible c ...... in inflammatory bowel disease.
@en
Hyperexpression of inducible c ...... in inflammatory bowel disease.
@nl
prefLabel
Hyperexpression of inducible c ...... in inflammatory bowel disease.
@en
Hyperexpression of inducible c ...... in inflammatory bowel disease.
@nl
P2093
P1433
P1476
Hyperexpression of inducible c ...... in inflammatory bowel disease
@en
P2093
Akira Okazawa
Hiromasa Ishii
Mamoru Watanabe
Motomi Yamazaki
Nagamu Inoue
Richard A Kroczek
Susumu Okamoto
Takaaki Nakai
Takanori Kanai
Teruji Totsuka
P304
P356
10.1053/J.GASTRO.2003.12.011
P407
P577
2004-03-01T00:00:00Z